Characteristics and trend analysis of cancer mortality among residents of the Xizang autonomous region, 2014-2023.

IF 3.4 2区 医学 Q2 ONCOLOGY BMC Cancer Pub Date : 2025-03-22 DOI:10.1186/s12885-024-13376-2
Pingcuo Zhuoma, Gama Cangjue, Hui Wang, Jinlei Qi
{"title":"Characteristics and trend analysis of cancer mortality among residents of the Xizang autonomous region, 2014-2023.","authors":"Pingcuo Zhuoma, Gama Cangjue, Hui Wang, Jinlei Qi","doi":"10.1186/s12885-024-13376-2","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The Xizang Autonomous Region, located in China's southwestern frontier with an average elevation of 4000 m, faces socioeconomic development challenges influenced by its natural environment and regional disparities. Previous studies have indicated that cancer ranks as the fourth leading cause of death among permanent residents in Xizang. However, there is a paucity of research on the trends and characteristics of cancer mortality in this region. This study aims to analyze mortality data from Xizang between 2014 and 2023 to elucidate the characteristics and trends of cancer deaths and to provide a foundation for developing effective cancer prevention and treatment strategies.</p><p><strong>Methods: </strong>Mortality data for cancer patients from 2014 to 2023 were extracted from the Death Information Registration and Management System of the Chinese Center for Disease Control and Prevention (CDC). The population data for Xizang were obtained from the Basic Information System of the Chinese CDC. Crude and age-standardized mortality rates were computed via SPSS software, and joinpoint regression models were employed to estimate the average annual percent change (AAPC) in mortality trends.</p><p><strong>Results: </strong>Between 2014 and 2023, the crude mortality rate (CMR) for cancer increased from 31.38 per 100,000 to 49.37 per 100,000, whereas the age-standardized mortality rate (ASMR) rose from 50.15 per 100,000 to 66.42 per 100,000, with annual increases of 4.59% and 2.12%, respectively. The leading causes of cancer death are liver cancer, stomach cancer, lung cancer, esophageal cancer, and cervical cancer.</p><p><strong>Conclusion: </strong>Cancer mortality in Xizang is increasing, with higher rates in men than in women, although the rate of increase is faster in women. Mortality rates increase with age, predominantly affecting middle-aged and elderly populations. Liver and stomach cancers are the primary contributors to cancer mortality. Given the severe cancer control situation, comprehensive prevention strategies and early diagnosis and treatment for high-risk populations are crucial.</p>","PeriodicalId":9131,"journal":{"name":"BMC Cancer","volume":"25 1","pages":"525"},"PeriodicalIF":3.4000,"publicationDate":"2025-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11929983/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12885-024-13376-2","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The Xizang Autonomous Region, located in China's southwestern frontier with an average elevation of 4000 m, faces socioeconomic development challenges influenced by its natural environment and regional disparities. Previous studies have indicated that cancer ranks as the fourth leading cause of death among permanent residents in Xizang. However, there is a paucity of research on the trends and characteristics of cancer mortality in this region. This study aims to analyze mortality data from Xizang between 2014 and 2023 to elucidate the characteristics and trends of cancer deaths and to provide a foundation for developing effective cancer prevention and treatment strategies.

Methods: Mortality data for cancer patients from 2014 to 2023 were extracted from the Death Information Registration and Management System of the Chinese Center for Disease Control and Prevention (CDC). The population data for Xizang were obtained from the Basic Information System of the Chinese CDC. Crude and age-standardized mortality rates were computed via SPSS software, and joinpoint regression models were employed to estimate the average annual percent change (AAPC) in mortality trends.

Results: Between 2014 and 2023, the crude mortality rate (CMR) for cancer increased from 31.38 per 100,000 to 49.37 per 100,000, whereas the age-standardized mortality rate (ASMR) rose from 50.15 per 100,000 to 66.42 per 100,000, with annual increases of 4.59% and 2.12%, respectively. The leading causes of cancer death are liver cancer, stomach cancer, lung cancer, esophageal cancer, and cervical cancer.

Conclusion: Cancer mortality in Xizang is increasing, with higher rates in men than in women, although the rate of increase is faster in women. Mortality rates increase with age, predominantly affecting middle-aged and elderly populations. Liver and stomach cancers are the primary contributors to cancer mortality. Given the severe cancer control situation, comprehensive prevention strategies and early diagnosis and treatment for high-risk populations are crucial.

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
2014-2023年西藏自治区居民癌症死亡率特征及趋势分析
背景:西藏自治区地处中国西南边疆,平均海拔4000米,受自然环境和区域差异的影响,经济社会发展面临诸多挑战。此前的研究表明,癌症是西藏常住居民的第四大死因。然而,关于该地区癌症死亡率的趋势和特征的研究却很缺乏。本研究旨在分析西藏省2014 - 2023年癌症死亡数据,阐明癌症死亡的特征和趋势,为制定有效的癌症防治策略提供依据。方法:从中国疾病预防控制中心死亡信息登记管理系统中提取2014 - 2023年癌症患者死亡率数据。西藏省人口数据来源于中国疾病预防控制中心基本信息系统。通过SPSS软件计算粗死亡率和年龄标准化死亡率,并采用连接点回归模型估计死亡率趋势的年均百分比变化(AAPC)。结果:2014 - 2023年,肿瘤粗死亡率(CMR)由31.38 / 10万上升至49.37 / 10万,年龄标准化死亡率(ASMR)由50.15 / 10万上升至66.42 / 10万,年均分别上升4.59%和2.12%。导致癌症死亡的主要原因是肝癌、胃癌、肺癌、食道癌和宫颈癌。结论:西藏省癌症死亡率呈上升趋势,男性死亡率高于女性,但女性死亡率上升较快。死亡率随年龄增长而增加,主要影响到中老年人口。肝癌和胃癌是导致癌症死亡的主要原因。鉴于癌症控制形势严峻,综合预防策略和对高危人群的早期诊断和治疗至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
BMC Cancer
BMC Cancer 医学-肿瘤学
CiteScore
6.00
自引率
2.60%
发文量
1204
审稿时长
6.8 months
期刊介绍: BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular biology, genetics, epidemiology, and clinical trials.
期刊最新文献
Investigating the causal link between metformin and lung cancer risk: a two-sample mendelian randomization analysis. Incidence, patterns of clinical presentation, and haematological characteristics of paediatric acute myeloid leukaemia in Uganda: a retrospective analysis. Supervised machine learning to quantitatively assess the prognostic value of tumor-infiltrating lymphocytes in gastric cancer. Interpretable machine learning using CT radiomics predicts pathological upgrading after secondary resection in non-muscle-invasive bladder cancer. Efficacy and safety of 7-day aerosolized epigallocatechin-3-gallate in oncologic patients with COVID-19 pneumonia.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1